Skip to content

Study on Indomethacin-responsive Headaches

Non Interventional Study on Indomethacin-responsive Headaches

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03967483
Enrollment
100
Registered
2019-05-30
Start date
2019-06-01
Completion date
2021-06-01
Last updated
2019-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache, Migraine

Brief summary

Description of modalities concerning the patient care of headaches sensible to indometacine.

Detailed description

Description of clinical profile, treatment of crisis and background treatment

Interventions

patient who are taken indomatacin for headaches and migraine

Sponsors

Anne Ducros
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* patient with a diagnosis of migraine with or without aura, or trigemino-autosomic headaches or other primary headaches * patient who are taking indometacine * patient with written consent form

Exclusion criteria

* patient under 18 years * pregnant woman or breastfeeding patient * patient who refuses to participate

Design outcomes

Primary

MeasureTime frameDescription
Description of headaches sensible to indometacine24 monthesDescription of the clinical cases with headaches sensible to indometacine according to the type of headaches.

Contacts

Primary ContactAnne DONNET
Anne.DONNET@ap-hm.fr0491384340

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026